Services and Research

IRFCID is focused on supporting the development and delivery of various therapeutic applications to treat chronic immune, autoimmune and late stage cancers. Leading areas of interest are the further research and development of autologus vaccines, Cytokines, Transfer Factor, natural killer cells, and low doses of neoplastic chemotherapeutic agents combined with insulin. Cytokines stimulate T- Cell activity in a depressed immune system without regard to the etiology. Cytokine activity is then supported by the use of a biologically developed Transfer Factor to modulate the weakened immune system. The cytotoxic effect of extremely high doses of ascorbic acid mixed with a proprietary formulation of vitamins and minerals to support immune system modulation has been shown to be efficacious in human clinical applications.

IRFCID-funded research encompasses the most innovative applications of conventional therapies (chemotherapy, radiation and surgery) and the best in science-based complementary medicine (nutrition, biofeedback, psychoneuro immunology, spiritual, etc).